When you use a copier, hit a golf ball, or listen to a CD, you're using technologies developed by Battelle Memorial Institute. The not-for-profit is one of the world's largest research enterprises, with more than 22,000 scientists, engineers, and staff serving corporate and government clients. Research areas include national security, energy, and health and life sciences. Battelle owns facilities in the US, Asia, and Europe and manages four Department of Energy-sponsored labs: Brookhaven National Laboratory, Oak Ridge National Laboratory, Idaho National Laboratory, and Pacific Northwest National Laboratory. The institute was established by the family of steel industry pioneer Gordon Battelle in 1929.
The company's headquarters are located in Columbus, Ohio. Battelle has about 130 locations globally.
Battelle’s major subsidiaries include Battelle Arabia, Battelle India, Battelle Japan, Battelle Ventures, Bluefin Robotics, and Winner Water Services.
Sales and Marketing
The company serves the national security, health and life sciences, and energy and environmental industries. Battelle’s major customer group includes government and commercial organizations in Laboratory Management, National Security, Health & Pharmaceutical, Energy & Environment, Consumer & Industrial, and STEM Education.
In 2012 the company signed an exclusive licensing and collaboration agreement with the specialty grid management company Gridquant, bringing breakthrough modeling and analysis technologies to the electricity transmission market. The agreement makes Battelle the exclusive provider of consulting services in the US and Canada and enables Battelle to help grid operators accurately visualize and manage the state of the grid, which is one of the most pressing challenges in electricity transmission management.
Also in 2012 the company formed a co-marketing and technology development partnership with Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain with the objective of advancing the development and commercialization of Zogenix's DosePro drug delivery technology outside Zogenix's core therapeutic focus areas.
Battelle is in the process of building an advanced research-and-development facility that will expand its global footprint and capacity to provide advanced science and technology solutions for the agriculture, food and health care industries. The new facility will augment Battelle’s established global scientific expertise in formulation development, toxicology and biotechnology programs that help agriculture and food customers accelerate product development and meet multi-national regulatory requirements.